HR 565

                                                 PRINTER'S NO.   3596
                THE GENERAL ASSEMBLY OF PENNSYLVANIA
      HOUSE RESOLUTION
         No. 565
                                           Session of
                                             2026
INTRODUCED BY McNEILL, VENKAT, GREINER, DOUGHERTY, COOK,
   DIAMOND, HOHENSTEIN, McANDREW, GUZMAN, GUENST, NEILSON,
   RIVERA, COOPER, CONKLIN, PASHINSKI, SANCHEZ, DEASY AND
   CIRESI, JUNE 10, 2026
REFERRED TO COMMITTEE ON HEALTH, JUNE 12, 2026
                            A RESOLUTION
1 Designating the month of September 2026 as "Prostate Cancer
2    Awareness Month" in Pennsylvania.
3    WHEREAS, The prostate is a small gland found only in men and
4 located below the bladder; and
5    WHEREAS, In some cases, prostate cancer can make the prostate
6 enlarged; and
7    WHEREAS, Prostate Cancer Research, a nonprofit organization
8 under the National Cancer Research Institute, reports that the
9 risk of prostate cancer increases with age with most cases
10 diagnosed in men over 50 years of age; and
11    WHEREAS, According to the Prostate Conditions Education
12 Council, 1 in 8 American men will get prostate cancer and 1 in
13 41 men will die from prostate cancer; and
14    WHEREAS, The American Cancer Society estimated that more than
15 13,000 new cases of prostate cancer will have been diagnosed in
16 2025 in Pennsylvania; and
17    WHEREAS, The American Cancer Society estimated that 1,500
1 Pennsylvanians will have died of prostate cancer in 2025; and
2    WHEREAS, The Centers for Disease Control and Prevention
3 describes symptoms of prostate cancer that include difficulty
4 starting urination, weak or interrupted flow of urine, trouble
5 emptying the bladder completely, pain or burning during
6 urination, blood in the urine and pain in the back, hips or
7 pelvis; and
8    WHEREAS, Prostate cancer can be dormant in a person's body
9 for up to 20 years without symptoms, increasing the chance that
10 a person may be sick without the person's knowledge; and
11    WHEREAS, The American Cancer Society recommends that men with
12 an average risk of prostate cancer start screening for prostate
13 cancer at 50 years of age; and
14    WHEREAS, For men at a high risk of developing prostate cancer
15 and men who have a first-degree relative diagnosed with prostate
16 cancer at an early age, screening should begin at 45 years of
17 age; and
18    WHEREAS, For men at even greater risk, including those with
19 more than one first-degree relative who had prostate cancer at
20 an early age, screening should begin at 40 years of age; and
21    WHEREAS, Men should consult with their physician about the
22 benefits of screening for prostate cancer; and
23    WHEREAS, There are two tests used by physicians to screen for
24 prostate cancer: a prostate-specific antigen test, which
25 measures the level of prostate-specific antigen in the blood,
26 and a digital rectal examination, which detects abnormalities of
27 the prostate; and
28    WHEREAS, If abnormalities are noted from either screening, a
29 biopsy may be recommended to assist in diagnosing potential
30 prostate cancer; therefore be it
20260HR0565PN3596  - 2 -
1    RESOLVED, That the House of Representatives designate the
2 month of September 2026 as "Prostate Cancer Awareness Month" in
3 Pennsylvania.
20260HR0565PN3596  - 3 -